Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain

Neuropsychopharmacology

Volumn 39, Issue 11, 2014, Pages 2633-2645

  Tran, Lee ^a   Schulkin, Jay ^b   Greenwood Van Meerveld, Beverley ^a,c,d  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3,6-DIMETHYL-2-(2,4,6-TRIMETHYLPHENOXY)PYRIDIN-4-YL)(1-ETHYLPROPYL)AMINE; AMINOPYRIDINE DERIVATIVE; ASTRESSIN-2B; CENTRAL NERVOUS SYSTEM AGENTS; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLOPEPTIDE; PEPTIDE FRAGMENT;

ANIMAL; ANTAGONISTS AND INHIBITORS; ANXIETY; COMORBIDITY; DRUG EFFECTS; EXPLORATORY BEHAVIOR; FISCHER 344 RAT; HYPERALGESIA; MALE; MAZE TEST; MENTAL STRESS; METABOLISM; PAIN; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSIOLOGY; SENSORY GATING; SEPTUM NUCLEUS; STIMULATION;

AMINOPYRIDINES; ANIMALS; ANXIETY; CENTRAL NERVOUS SYSTEM AGENTS; COMORBIDITY; EXPLORATORY BEHAVIOR; HYPERALGESIA; MALE; MAZE LEARNING; PAIN; PAIN THRESHOLD; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; PHYSICAL STIMULATION; RATS, INBRED F344; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SENSORY GATING; SEPTAL NUCLEI; STRESS, PSYCHOLOGICAL;

EID: 84922723193     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.117     Document Type: Article

References (69)

1. Allen C, Kendall JW (1967). Maturation of the circadian rhythm of plasma corticosterone in the rat. Endocrinology 80: 926-930.
2. Berman SM, Naliboff BD, Suyenobu B, Labus JS, Stains J, Ohning G et al (2008). Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J Neurosci 28: 349-359.
3. Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF et al (2002). Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol 97: 654-661.
4. Bonaz BL, Bernstein CN (2013). Brain-gut interactions in inflammatory bowel disease. Gastroenterology 144: 36-49.
5. Bradesi S, Schwetz I, Ennes HS, Lamy CM, Ohning G, Fanselow M et al (2005). Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol 289: G42-G53.
6. Cecchi M, Khoshbouei H, Javors M, Morilak DA (2002). Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience 112: 13-21.
7. Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A et al (2009). Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 21: 149-159.
8. Chen CY, Inui A, Asakawa A, Fujino K, Kato I, Chen CC et al (2005). Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 129: 8-25.
9. Choi DC, Furay AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, Herman JP (2007). Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J Neurosci 27: 2025-2034.
10. Conti LH (2005). Characterization of the effects of corticotropinreleasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats. Eur J Pharmacol 507: 125-134.
11. Conti LH, Murry JD, Ruiz MA, Printz MP (2002). Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains. Psychopharmacology (Berl) 161: 296-303.
12. Dabrowska J, Hazra R, Ahern TH, Guo JD, McDonald AJ, Mascagni F et al (2011). Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affect. Psychoneuroendocrinology 36: 1312-1326.
13. Davis M, Shi C (1999). The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Ann N Y Acad Sci 877: 281-291.
14. Davis M, Walker DL, Lee Y (1997). Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD. Ann N Y Acad Sci 821: 305-331.
15. Deyama S, Nakagawa T, Kaneko S, Uehara T, Minami M (2007). Involvement of the bed nucleus of the stria terminalis in the negative affective component of visceral and somatic pain in rats. Behav Brain Res 176: 367-371.
16. Dhabhar FS, McEwen BS, Spencer RL (1997). Adaptation to prolonged or repeated stress-comparison between rat strains showing intrinsic differences in reactivity to acute stress. Neuroendocrinology 65: 360-368.
17. Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L et al (2006). Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130: 304-311.
18. Dong HW, Swanson LW (2004). Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis. J Comp Neurol 468: 277-298.
19. Erb S, Shaham Y, Stewart J (2001). Stress-induced relapse to drug seeking in the rat: role of the bed nucleus of the stria terminalis and amygdala. Stress 4: 289-303.
20. Fu Y, Neugebauer V (2008). Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J Neurosci 28: 3861-3876.
21. Fukudo S (2013). Stress and visceral pain: focusing on irritable bowel syndrome. Pain 154(Suppl 1): S63-S70.
22. Gibney SM, Gosselin RD, Dinan TG, Cryan JF (2010). Colorectal distension-induced prefrontal cortex activation in the Wistar-Kyoto rat: implications for irritable bowel syndrome. Neuroscience 165: 675-683.
23. Greenwood-Van Meerveld B, Gibson M, Gunter W, Shepard J, Foreman R, Myers D (2001). Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats. Brain Res 893: 135-142.
24. Greenwood-Van Meerveld B, Johnson AC, Cochrane S, Schulkin J, Myers DA (2005). Corticotropin-releasing factor 1 receptormediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol Motil 17: 415-422.
25. Hammack SE, Mania I, Rainnie DG (2007). Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol 98: 638-656.
26. Herman JP, Cullinan WE, Watson SJ (1994). Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J Neuroendocrinol 6: 433-442.
27. Herman JP, Tasker JG, Ziegler DR, Cullinan WE (2002). Local circuit regulation of paraventricular nucleus stress integration: glutamate-GABA connections. Pharmacol Biochem Behav 71: 457-468.
28. Hubbard CS, Ornitz E, Gaspar JX, Smith S, Amin J, Labus JS et al (2011). Modulation of nociceptive and acoustic startle responses to an unpredictable threat in men and women. Pain 152: 1632-1640.
29. Ji G, Neugebauer V (2008). Pro-and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors. J Neurophysiol 99: 1201-1212.
30. Johnson AC, Tran L, Schulkin J, Greenwood-Van Meerveld B (2012). Importance of stress receptor-mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious rat. Neurogastroenterol Motil 24: 479-486.
31. Koch M, Schnitzler HU (1997). The acoustic startle response in rats-circuits mediating evocation, inhibition and potentiation. Behav Brain Res 89: 35-49.
32. Lee Y, Davis M (1997). Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci 17: 6434-6446.
33. Lee Y, Lopez DE, Meloni EG, Davis M (1996). A primary acoustic startle pathway: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalis. J Neurosci 16: 3775-3789.
34. Makino S, Gold PW, Schulkin J (1994). Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 640: 105-112.
35. McEwen BS (1998). Protective and damaging effects of stress mediators. N Engl J Med 338: 171-179.
36. McEwen BS, Gianaros PJ (2010). Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann N Y Acad Sci 1186: 190-222.
37. Myers B, Greenwood-Van Meerveld B (2007). Corticosteroid receptor-mediated mechanisms in the amygdala regulate anxiety and colonic sensitivity. Am J Physiol Gastrointest Liver Physiol 292: G1622-G1629.
38. Myers B, Greenwood-Van Meerveld B (2010). Elevated corticosterone in the amygdala leads to persistent increases in anxiety-like behavior and pain sensitivity. Behav Brain Res 214: 465-469.
39. Myers B, Greenwood-Van Meerveld B (2012). Differential involvement of amygdala corticosteroid receptors in visceral hyperalgesia following acute or repeated stress. Am J Physiol Gastrointest Liver Physiol 302: 6260-6266.
40. Myers B, Mark Dolgas C, Kasckow J, Cullinan WE, Herman JP (2013). Central stress-integrative circuits: forebrain glutamatergic and GABAergic projections to the dorsomedial hypothalamus, medial preoptic area, and bed nucleus of the stria terminalis. Brain Struct Funct (epub ahead of print, doi:10.1007/s00429-013-0566-y).
41. Myers DA, Gibson M, Schulkin J, Greenwood Van-Meerveld B (2005). Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity. Behav Brain Res 161: 39-44.
42. Naliboff BD, Berman S, Suyenobu B, Labus JS, Chang L, Stains J et al (2006). Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology 131: 352-365.
43. Naliboff BD, Waters AM, Labus JS, Kilpatrick L, Craske MG, Chang L et al (2008). Increased acoustic startle responses in IBS patients during abdominal and nonabdominal threat. Psychosom Med 70: 920-927.
44. Nijsen M, Ongenae N, Meulemans A, Coulie B (2005). Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain. Neurogastroenterol Motil 17: 423-432.
45. Ohmura Y, Izumi T, Yamaguchi T, Tsutsui-Kimura I, Yoshida T, Yoshioka M (2010). The serotonergic projection from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the corticotropin-releasing factor type 2 receptor. Neuropsychopharmacology 35: 1271-1278.
46. Radley JJ, Sawchenko PE (2011). A common substrate for prefrontal and hippocampal inhibition of the neuroendocrine stress response. J Neurosci 31: 9683-9695.
47. Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A (2004). Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 24: 3471-3479.
48. Regev L, Tsoory M, Gil S, Chen A (2012). Site-specific genetic manipulation of amygdala corticotropin-releasing factor reveals its imperative role in mediating behavioral response to challenge. Biol Psychiatry 71: 317-326.
49. Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA (2004). Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci 24: 6545-6552.
50. Rosen JB, Schulkin J (1998). From normal fear to pathological anxiety. Psychol Rev 105: 325-350.
51. Sahuque LL, Kullberg EF, McGeehan AJ, Kinder JR, Hicks MP, Blanton MG et al (2006). Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl) 186: 122-132.
52. Schulkin J, Gold PW, McEwen BS (1998). Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology 23: 219-243.
53. Shepard JD, Barron KW, Myers DA (2000). Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 861: 288-295.
54. Shepard JD, Barron KW, Myers DA (2003). Stereotaxic localization of corticosterone to the amygdala enhances hypothalamopituitary-adrenal responses to behavioral stress. Brain Res 963: 203-213.
55. Sink KS, Walker DL, Freeman SM, Flandreau EI, Ressler KJ, Davis M (2013). Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Mol Psychiatry 18: 308-319.
56. Sternberg EM, Glowa JR, Smith MA, Calogero AE, Listwak SJ, Aksentijevich S et al (1992). Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res 570: 54-60.
57. Stout SC, Mortas P, Owens MJ, Nemeroff CB, Moreau J (2000). Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. Eur J Pharmacol 401: 39-46.
58. Tanaka Y, Morishita J, Kanazawa M, Hamaguchi T, Tashiro M, Fukudo S (2011). Corticotropin-releasing hormone is associated with exaggerated brain activity and pituitary-adrenal response during colorectal distention in men. Gastroenterology 140: S57.
59. Thompson RH, Swanson LW (2003). Structural characterization of a hypothalamic visceromotor pattern generator network. Brain Res Brain Res Rev 41: 153-202.
60. Tran L, Chaloner A, Sawalha AH, Greenwood Van-Meerveld B (2013). Importance of epigenetic mechanisms in visceral pain induced by chronic water avoidance stress. Psychoneuroendocrinology 38: 898-906.
61. Tran L, Greenwood-Van Meerveld B (2012a). Altered expression of glucocorticoid receptor and corticotropin-releasing factor in the central amygdala in response to elevated corticosterone. Behav Brain Res 234: 380-385.
62. Tran L, Greenwood-Van Meerveld B (2012b). Lateralized amygdala activation: importance in the regulation of anxiety and pain behavior. Physiol Behav 105: 371-375.
63. Tran L, Wiskur B, Greenwood-Van Meerveld B (2012c). The role of the anteriolateral bed nucleus of the stria terminalis in stressinduced nociception. Am J Physiol Gastrointest Liver Physiol 302: G1301-G1309.
64. Venkova K, Johnson AC, Myers B, Greenwood-Van Meerveld B (2010). Exposure of the amygdala to elevated levels of corticosterone alters colonic motility in response to acute psychological stress. Neuropharmacology 58: 1161-1167.
65. Ventura-Silva AP, Pego JM, Sousa JC, Marques AR, Rodrigues AJ, Marques F et al (2012). Stress shifts the response of the bed nucleus of the stria terminalis to an anxiogenic mode. Eur J Neurosci 36: 3396-3406.
66. Walker DL, Toufexis DJ, Davis M (2003). Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463: 199-216.
67. Watts AG, Sanchez-Watts G (1995). Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone. J Physiol 484(Pt 3): 721-736.
68. Zhou Q, Fillingim RB, Riley JL 3rd, Malarkey WB, Verne GN (2010). Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain 148: 454-461.
69. Zorrilla EP, Roberts AJ, Rivier JE, Koob GF (2013). Anxiolytic-like effects of antisauvagine-30 in mice are not mediated by CRF2 receptors. PLoS ONE 8: e63942.